• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Hopelessness in Patients with Early-Stage Relapsing-Remitting Multiple Sclerosis.早期复发缓解型多发性硬化症患者的绝望感
Patient Prefer Adherence. 2023 Jun 14;17:1431-1439. doi: 10.2147/PPA.S411069. eCollection 2023.
2
Long-term prognosis communication preferences in early-stage relapsing-remitting multiple sclerosis.早期复发缓解型多发性硬化症的长期预后沟通偏好。
Mult Scler Relat Disord. 2022 Aug;64:103969. doi: 10.1016/j.msard.2022.103969. Epub 2022 Jun 14.
3
Measuring productivity loss in early relapsing-remitting multiple sclerosis.测量早期复发缓解型多发性硬化症的生产力损失。
Mult Scler Relat Disord. 2022 Feb;58:103398. doi: 10.1016/j.msard.2021.103398. Epub 2021 Nov 10.
4
Decisional Conflict Regarding Disease-Modifying Treatment Choices Among Patients with Mid-Stage Relapsing-Remitting Multiple Sclerosis.中度复发缓解型多发性硬化症患者在疾病修饰治疗选择上的决策冲突
Patient Prefer Adherence. 2024 Jun 7;18:1163-1171. doi: 10.2147/PPA.S459242. eCollection 2024.
5
Perceived illness-related uncertainty among patients with mid-stage relapsing-remitting multiple sclerosis.中期复发缓解型多发性硬化症患者的疾病相关不确定性感知。
Mult Scler Relat Disord. 2024 Nov;91:105861. doi: 10.1016/j.msard.2024.105861. Epub 2024 Sep 3.
6
Delayed cognitive processing and treatment status quo bias in early-stage multiple sclerosis.早期多发性硬化症中的延迟认知加工与治疗现状偏差
Mult Scler Relat Disord. 2022 Dec;68:104138. doi: 10.1016/j.msard.2022.104138. Epub 2022 Aug 20.
7
Outcomes of natalizumab treatment within 3 years of relapsing-remitting multiple sclerosis diagnosis: a prespecified 2-year interim analysis of STRIVE.复发缓解型多发性硬化症诊断后3年内那他珠单抗治疗的结果:STRIVE研究的一项预先设定的2年中期分析
BMC Neurol. 2019 Jun 8;19(1):116. doi: 10.1186/s12883-019-1337-z.
8
Workplace difficulties, health-related quality of life, and perception of stigma from the perspective of patients with Multiple Sclerosis.多发性硬化症患者视角下的工作场所困难、与健康相关的生活质量和污名感知。
Mult Scler Relat Disord. 2020 Jun;41:102046. doi: 10.1016/j.msard.2020.102046. Epub 2020 Mar 7.
9
Hopelessness ratings in relapsing-remitting and secondary progressive multiple sclerosis.复发缓解型和继发进展型多发性硬化症中的绝望感评分
Int J Psychiatry Med. 2002;32(2):155-65. doi: 10.2190/2G2N-WE19-NM47-JNY8.
10
Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis.干扰素β治疗与复发缓解型多发性硬化患者残疾进展的相关性。
JAMA. 2012 Jul 18;308(3):247-56. doi: 10.1001/jama.2012.7625.

引用本文的文献

1
A new framework for understanding stress and disease: the developmental model of stress as applied to multiple sclerosis.一种理解压力与疾病的新框架:应用于多发性硬化症的压力发展模型。
Front Integr Neurosci. 2024 Jun 17;18:1365672. doi: 10.3389/fnint.2024.1365672. eCollection 2024.
2
Assessing illness-related uncertainty in relapsing-remitting multiple sclerosis: A psychometric analysis of the Mishel Uncertainty of Illness Scale.评估复发缓解型多发性硬化症中与疾病相关的不确定性:疾病不确定性米舍尔量表的心理测量分析
Mult Scler J Exp Transl Clin. 2024 Apr 18;10(2):20552173241247680. doi: 10.1177/20552173241247680. eCollection 2024 Apr-Jun.

本文引用的文献

1
Do patients diagnosed with a neurological disease present increased risk of suicide?被诊断患有神经疾病的患者自杀风险会增加吗?
Neurologia (Engl Ed). 2023 Jan-Feb;38(1):41-46. doi: 10.1016/j.nrleng.2020.03.005. Epub 2022 Sep 24.
2
Illness perceptions and outcome in multiple sclerosis: A systematic review of the literature.多发性硬化症的疾病认知与结局:文献系统综述。
Mult Scler Relat Disord. 2022 Nov;67:104180. doi: 10.1016/j.msard.2022.104180. Epub 2022 Sep 13.
3
Toward Precision Phenotyping of Multiple Sclerosis.迈向多发性硬化症的精准表型分析。
Neurol Neuroimmunol Neuroinflamm. 2022 Aug 30;9(6). doi: 10.1212/NXI.0000000000200025. Print 2022 Nov.
4
Gains in multiple sclerosis knowledge following completion of the Understanding Multiple Sclerosis online course are maintained six months after course completion.完成《了解多发性硬化症》在线课程后,多发性硬化症知识会有所增加,并且在课程结束后 6 个月仍能保持。
Mult Scler Relat Disord. 2022 Nov;67:104085. doi: 10.1016/j.msard.2022.104085. Epub 2022 Jul 31.
5
The value of patient-reported outcome measures for multiple sclerosis.患者报告的多发性硬化症结局指标的价值
Mult Scler. 2022 Sep;28(10):1489-1490. doi: 10.1177/13524585221111675.
6
The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: Progresses and open questions.全球多发性硬化症患者报告结局指标(PROMs)倡议议程:进展与未决问题。
Mult Scler Relat Disord. 2022 May;61:103757. doi: 10.1016/j.msard.2022.103757. Epub 2022 Mar 23.
7
Effects of Psychotherapy on Hope/Hopelessness in Adults with Cancer: a Systematic Review and Meta-analysis.心理治疗对成年癌症患者希望/绝望感的影响:一项系统评价与荟萃分析
Int J Behav Med. 2022 Dec;29(6):691-704. doi: 10.1007/s12529-021-10051-9. Epub 2022 Feb 8.
8
How I see is how I feel. Identification of illness perception schema and its association with adaptation outcomes in multiple sclerosis - a 5-year prospective study.我所见即我所感。多发性硬化症中疾病认知模式的识别及其与适应结局的关联——一项为期 5 年的前瞻性研究。
PLoS One. 2021 Oct 28;16(10):e0258740. doi: 10.1371/journal.pone.0258740. eCollection 2021.
9
Diagnosis and Treatment of Multiple Sclerosis: A Review.多发性硬化症的诊断与治疗:综述。
JAMA. 2021 Feb 23;325(8):765-779. doi: 10.1001/jama.2020.26858.
10
The common sense model of illness self-regulation: a conceptual review and proposed extended model.疾病自我调节的常识模型:概念综述与扩展模型建议
Health Psychol Rev. 2022 Sep;16(3):347-377. doi: 10.1080/17437199.2021.1878050. Epub 2021 Feb 1.

早期复发缓解型多发性硬化症患者的绝望感

Hopelessness in Patients with Early-Stage Relapsing-Remitting Multiple Sclerosis.

作者信息

Sainz de la Maza Susana, Maurino Jorge, Castillo-Triviño Tamara, Borges Mónica, Sebastián Torres Berta, Sotoca Javier, Alonso Torres Ana María, Caminero Ana B, Borrega Laura, Sánchez-Menoyo José L, Barrero-Hernández Francisco J, Calles Carmen, Brieva Luis, Blasco María Rosario, Dotor García-Soto Julio, Rodríguez-Regal Ana, Navarro-Cantó Laura, Agüera-Morales Eduardo, Garcés Moisés, Carmona Olga, Gabaldón-Torres Laura, Forero Lucía, Hervás Mariona, Gómez-Ballesteros Rocío

机构信息

Department of Neurology, Hospital Universitario Ramón y Cajal, Madrid, Spain.

Medical Department, Roche Farma, Madrid, Spain.

出版信息

Patient Prefer Adherence. 2023 Jun 14;17:1431-1439. doi: 10.2147/PPA.S411069. eCollection 2023.

DOI:10.2147/PPA.S411069
PMID:37337517
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10277026/
Abstract

BACKGROUND

Hopelessness is a risk factor for depression and suicide. There is little information on this phenomenon among patients with relapsing-remitting multiple sclerosis (RRMS), one of the most common causes of disability and loss of autonomy in young adults. The aim of this study was to assess state hopelessness and its associated factors in early-stage RRMS.

METHODS

A multicenter, non-interventional study was conducted. Adult patients with a diagnosis of RRMS, a disease duration ≤ 3 years, and an Expanded Disability Status Scale (EDSS) score of 0-5.5 were included. The State-Trait Hopelessness Scale (STHS) was used to measure patients´ hopelessness. A battery of patient-reported and clinician-rated measurements was used to assess clinical status. A multivariate logistic regression analysis was conducted to determine the association between patients' characteristics and state hopelessness.

RESULTS

A total of 189 patients were included. Mean age (standard deviation-SD) was 36.1 (9.4) years and 71.4% were female. Median disease duration (interquartile range-IQR) was 1.4 (0.7, 2.1) years. Symptom severity and disability were low with a median EDSS (IQR) score of 1.0 (0, 2.0). A proportion of 65.6% (n=124) of patients reported moderate-to-severe hopelessness. Hopelessness was associated with older age (p=0.035), depressive symptoms (p=<0.001), a threatening illness perception (p=0.001), and psychological and cognitive barriers to workplace performance (p=0.029) in the multivariate analysis after adjustment for confounders.

CONCLUSION

Hopelessness was a common phenomenon in early-stage RRMS, even in a population with low physical disability. Identifying factors associated with hopelessness may be critical for implementing preventive strategies helping patients to adapt to the new situation and cope with the disease in the long term.

摘要

背景

绝望是抑郁症和自杀的一个风险因素。在复发缓解型多发性硬化症(RRMS)患者中,关于这一现象的信息很少,RRMS是年轻成年人残疾和自主能力丧失的最常见原因之一。本研究的目的是评估早期RRMS患者的状态性绝望及其相关因素。

方法

进行了一项多中心、非干预性研究。纳入诊断为RRMS、病程≤3年且扩展残疾状态量表(EDSS)评分为0 - 5.5的成年患者。使用状态-特质绝望量表(STHS)测量患者的绝望程度。使用一系列患者报告和临床医生评定的测量方法来评估临床状态。进行多因素逻辑回归分析以确定患者特征与状态性绝望之间的关联。

结果

共纳入189例患者。平均年龄(标准差-SD)为36.1(9.4)岁,71.4%为女性。疾病持续时间中位数(四分位间距-IQR)为1.4(0.7,2.1)年。症状严重程度和残疾程度较低,EDSS(IQR)评分中位数为1.0(0,2.0)。65.6%(n = 124)的患者报告有中度至重度绝望。在对混杂因素进行调整后的多因素分析中,绝望与年龄较大(p = 0.035)、抑郁症状(p = <0.001)、对疾病的威胁感知(p = 0.001)以及工作场所表现的心理和认知障碍(p = 0.029)相关。

结论

绝望在早期RRMS中是一种常见现象,即使在身体残疾程度较低的人群中也是如此。识别与绝望相关的因素对于实施预防策略可能至关重要,这些策略有助于患者适应新情况并长期应对疾病。